Literature DB >> 19250269

Carbohydrate complexity and proportion of serum FSH isoforms reflect pituitary-ovarian activity in perimenopausal women and depot medroxyprogesterone acetate users.

Nazareth Loreti1, Verónica Ambao, Cassia Teatin Juliato, Cecilia Machado, Luis Bahamondes, Stella Campo.   

Abstract

BACKGROUND: FSH is synthesized and secreted in multiple glycosylation variants with different oligosaccharide structures; the endocrine milieu regulates the composition of FSH carbohydrate moiety.
OBJECTIVES: To characterize serum FSH isoforms according to their sialic acid content and oligosaccharide complexity in regularly menstruating women and in depot medroxyprogesterone acetate (DMPA) users during the menopausal transition. Subjects and methods Ten regularly menstruating perimenopausal women aged 45-52, with mid-follicular phase FSH levels < or =10 IU/l and 10 regularly menstruating women, aged 20-39, were included. Blood samples were collected on the ninth day of the menstrual cycle. Twenty DMPA users were divided into two groups (n = 10) according to age: DMPA(1), age range 20-39 and DMPA(2), age range 45-52. Blood samples were collected 90 +/- 5 days after the last injection of DMPA. Oestradiol (E(2)), inhibin B (Inh B), Pro-alphaC levels and the relative abundance of FSH isoforms on the basis of charge (preparative isoelectric focusing) and carbohydrate complexity (Concanavalin A chromatography) were determined.
RESULTS: Decreased Inh B and moderately elevated E(2) levels were observed in perimenopausal women associated with an increase in FSH sialylation and a decrease in its oligosaccharide complexity. DMPA induced changes in the hormonal profile and FSH molecular microheterogeneity; the secreted hormone was more heterogeneous and its oligosaccharides were less complex under this condition.
CONCLUSION: Serum FSH glycoforms with increased sialylation and decreased oligosaccharide complexity reflect the decline of the gonadal activity induced either by age or by the use of a DMPA as a contraceptive.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19250269     DOI: 10.1111/j.1365-2265.2009.03559.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  5 in total

1.  A human FSHB transgene encoding the double N-glycosylation mutant (Asn(7Δ) Asn(24Δ)) FSHβ subunit fails to rescue Fshb null mice.

Authors:  Huizhen Wang; Vladimir Butnev; George R Bousfield; T Rajendra Kumar
Journal:  Mol Cell Endocrinol       Date:  2016-02-19       Impact factor: 4.102

Review 2.  Changes in pituitary function with ageing and implications for patient care.

Authors:  Johannes D Veldhuis
Journal:  Nat Rev Endocrinol       Date:  2013-02-26       Impact factor: 43.330

3.  In vitro ovarian follicle growth: a comprehensive analysis of key protocol variables†.

Authors:  Leah E Simon; T Rajendra Kumar; Francesca E Duncan
Journal:  Biol Reprod       Date:  2020-08-21       Impact factor: 4.285

4.  Evaluation of in vivo bioactivities of recombinant hypo- (FSH21/18) and fully- (FSH24) glycosylated human FSH glycoforms in Fshb null mice.

Authors:  Huizhen Wang; Jacob May; Viktor Butnev; Bin Shuai; Jeffrey V May; George R Bousfield; T Rajendra Kumar
Journal:  Mol Cell Endocrinol       Date:  2016-08-22       Impact factor: 4.102

Review 5.  Heterogeneity and Dynamics of Vasculature in the Endocrine System During Aging and Disease.

Authors:  Sina Stucker; Jessica De Angelis; Anjali P Kusumbe
Journal:  Front Physiol       Date:  2021-03-09       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.